Devon Christie
Biographic Data
| ID | 3824514 |
|---|---|
| NAME | Devon Christie |
| GIVEN NAMES | Devon |
| FAMILY NAME | Christie |
| SIGNATURE | CHRISTIE D |
| AFFILIATIONS | University of British Columbia |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
Findings demonstrate a high prevalence of chronic pain in this sample of people with severe PTSD and that chronic pain scores among medium and high pain subgroups were significantly lower following MDMA-AT. While these data are preliminary, when considered alongside the frequency of comorbid chronic pain and PTSD and promising efficacy of MDMA-AT for treating PTSD, these findings encourage further research exploring the role of MDMA-AT for chroni…
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings
Despite growing availability of several evidence-based approaches in the treatment of substance use disorders, existing pharmacotherapy and psychosocial interventions continue to have significant limitations, such as low treatment retention rates and high rates of relapse. There is a need to develop new strategies and models to address these limitations and target underlying psychosocial drivers of addiction, such as motivation to change - a cruc…
Psychedelic-Assisted Psychotherapy After Covid-19
The COVID-19 pandemic stands to have impacts on mental health and well-being that will extend beyond its formal resolution. Before COVID-19, mental health disorders were already challenging global healthcare systems, directly accounting for 7.4% of the total burden of disease (1, 2). An estimated 1 billion people worldwide suffer from a mental health disorder, with the two most common disorders—depression and anxiety—costing the global economy US…
No prominent works on this page.
Psychedelic-Assisted Psychotherapy After Covid-19
The COVID-19 pandemic stands to have impacts on mental health and well-being that will extend beyond its formal resolution. Before COVID-19, mental health disorders were already challenging global healthcare systems, directly accounting for 7.4% of the total burden of disease (1, 2). An estimated 1 billion people worldwide suffer from a mental health disorder, with the two most common disorders—depression and anxiety—costing the global economy US…
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
Findings demonstrate a high prevalence of chronic pain in this sample of people with severe PTSD and that chronic pain scores among medium and high pain subgroups were significantly lower following MDMA-AT. While these data are preliminary, when considered alongside the frequency of comorbid chronic pain and PTSD and promising efficacy of MDMA-AT for treating PTSD, these findings encourage further research exploring the role of MDMA-AT for chroni…
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings
Despite growing availability of several evidence-based approaches in the treatment of substance use disorders, existing pharmacotherapy and psychosocial interventions continue to have significant limitations, such as low treatment retention rates and high rates of relapse. There is a need to develop new strategies and models to address these limitations and target underlying psychosocial drivers of addiction, such as motivation to change - a cruc…
Psychedelics and Drug Studies (4 works) · Psychiatry (4 works) · Psychology (4 works) · Medicine (3 works) · Neurotransmitter Receptor Influence on Behavior (3 works) · Chemical synthesis and alkaloids (2 works) · Clinical Psychology (2 works) · MDMA (2 works) · Mental health (2 works) · Psychotherapist (2 works)